Docstoc

William B Trattler, MD

Document Sample
William B Trattler, MD Powered By Docstoc
					                                  William B. Trattler, MD

                                    The Center for Excellence in Eye Care
                                    8940 North Kendall Drive, Suite 400E
                                           Miami, Florida 33176
                                               (305) 598-2020
                                          wtrattler@earthlink.net



CERTIFICATIO

10/98            BOARD CERTIFIED IN OPHTHALMOLOGY

EDUCATIO

7/96-7/97        UNIVERSITY OF TEXAS- SOUTHWESTERN MEDICAL SCHOOL, Dallas, Texas
                         Cornea and External Disease Fellowship

7/93- 7/96       UNIVERSITY OF PENNSYLVANIA/ SCHEIE EYE INSTITUTE
                         Ophthalmology Residency

7/92-6/93        MOUNT SINAI MEDICAL CENTER, Miami Beach, Florida
                        Internal Medicine Internship

9/88-5/92        UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, Miami, Florida
                         M.D. Degree with Research Distinction

9/84-6/88        DARTMOUTH COLLEGE, Hanover, New Hampshire
                       Bachelor of Arts in Biology, cum laude

EMPLOYME T

7/97-Present     THE CENTER FOR EXCELLENCE IN EYE CARE, Miami, Florida
                     Private Practice; Subspecialty: Cornea, External Disease, & Refractive Surgery

7/02-7/06        BASCOM PALMER EYE INSTITUTE; Miami, FL (3 half days per month)
                    Supervise Residents in the Bascom Palmer Eye Emergency Department
                    Instruct residents in anterior segment surgery (cataract and corneal surgery)

7/97-7/01        V.A. HOSPITAL, Miami, Florida
                      Surgical Staff: Supervising University of Miami ophthalmology residents in surgery & clinic


ACADEMIC APPOI TME TS

7/2000-Present   Volunteer Assistant Professor of Ophthalmology, Bascom Palmer Eye Institute


AWARDS A D HO ORS

12/07 :          Trusted LASIK Surgeons: Qualified and Listed at Trusted LASIK Surgeons, a LASIK directory service
                 that screens surgeons based on experience, premier patient care, and professional credentials
11/06            Poster 664: Delayed Epithelial Healing With epafenac Ophthalmic Solution was “selected as one of the
                 best posters at the 2006 Meeting of the American Academy of Ophthalmology”, Las Vegas, NV; Nov 13
                 2006
05/06            Achievement Award; American Academy of Ophthalmology


AWARDS A D HO ORS (continued)

                                                         1
                                     William B. Trattler, MD
04/06               Top 50 Cataract & Refractive Surgery Opinion Leaders, as voted on by readers of Cataract & Refractive
                    Surgery Today.
2006, 2008          Aspen Invitational Refractive Symposium: Ski Race Champion
2002                Curtis D. Benton, Jr., MD Outstanding Young Ophthalmologist Leadership Award; This award is
                    presented by the Florida Society of Ophthalmology (FSO) to a Florida ophthalmologist who has
                    demonstrated leadership, service, competence and devotion to the high ethical and professional standards
                    of the FSO.
1993-94 & 1995-96   Scheie Eye Institute Teaching Award
1994                Walter Stark, MD Award: “First Place Downhill Racer”, Current Concepts in Ophthalmology meeting,
                    Vail, Colorado
1991                Alpha Omega Alpha, Medical Honor Society
1989                John H. Fomon Memorial Research Fellowship, American Cancer Society: Support for ocular
                    immunology research
1987                Raynolds Expedition Fund Grant: Supported shark research in Bimini, Bahamas


RESEARCH POSITIO S/CLI ICAL TRIALS

4/08 to present:    Wavetec: a multi-center, prospective study of the wavetec vision systems aberrometer performed in
                    subjects undergoing cataract surgery
12/07 to present    A Multi-Center, Double-Masked, Randomized, Controlled, Parallel-Group, Three-Month Study (Plus
                    Three-Month, Masked Extension) to Evaluate the Safety and Efficacy of Twice-Daily Administered
                    Cyclosporine Ophthalmic Emulsion 0.05% (RESTASIS®) in Accelerating the Recovery of Corneal
                    Sensitivity in Post-LASIK Patients; PROTOCOL NUMBER: 192371-014-00 (Allergan)
12/07 to 12/07:     SURFACE: Surveillance of Resistance to Formulations of Antimicrobials in Cultures of the Eye
                    (Allergan)
11/07 to 1/08:      A Multi Center, Double Masked, Randomized Parallel Group Study Evaluating the Safety and Efficacy
                    of a New Formulation of Ketorolac Tromethamine 0.45% Ophthalmic Solution Compared with Vehicle
                    Administered Preoperatively and Twice-Daily Postoperatively for Two Weeks for the Treatment of
                    Anterior Segment Inflammation, Pain, and Inhibition of Surgically Induced Miosis Following Cataract
                    Extraction with Posterior Chamber Intraocular Lens (IOL) Implantation; Protocol #:191578-006
                    (Allergan); enrollment complete
11/07 to 1/08:      Efficacy and Safety of Bromfenac Ophthalmic Solution 0.18% QD vs. Xibrom™ (BromfenacOphthalmic
                    Solution) 0.09% QD for Treatment of Ocular Inflammation, Pain, and Photophobia Associated with
                    Cataract Surgery; Enrollment Complete
10/07 to 4/08:      A Multi-Center, Double-Masked, Randomized, Two-Arm, Parallel-Group Study to Compare the
                    Efficacy, Safety and Acceptability of Optive™ Unit-Dose Eye Drops with Refresh Plus® Unit-Dose
                    Lubricant Eye Drops for Three Months in Subjects following LASIK Refractive Surgery Status:
                    PROTOCOL NUMBER: AG9818-001-00 (Allergan)
8/07 to present:    A 6 Day, Phase 3, Multicenter, Randomized, Double-Masked, Parallel Study to Compare the Safety and
                    Efficacy of Gatifloxacin 0.5% Ophthalmic Solution BID with that of Vehicle in the Treatment of Acute
                    Bacterial Conjunctivitis; PROTOCOL #: 198782-004-00 (Allergan)
8/07 to present:    A Phase 3 Double-Masked, Randomized Study of the Safety and Effectiveness of DYME (Brilliant Blue)
                    as an Agent for Selective Staining of the Anterior Capsule during Cataract Surgery; Protocol AQNA-
                    DY001: (Aqumen Biopharmaceuticals N.A., Inc.)
8/07 to 4/08:       “A Multicenter, Masked Evaluation of Ocular Surface Tolerability Associated with Bimatoprost 0.03%,
                    Travoprost 0.004% (BAK free) or Latanoprost 0.005% Therapy in pts with Glaucoma or OHTN”



                                                            2
                                    William B. Trattler, MD
7/07 to present:   Phase 3 study: An Open-Label, Safety Evaluation of Cyclosporine A Ophthalmic Solution, 0.1% (ST-
                   603) Administered Twice Daily for 12 Months to Subjects With Dry Eye Syndrome (ST-603-006)
6/07 to 11/07:     Phase 3 Study of the Efficacy and Safety of Cyclosporine Ophthalmic Solution, 0.1% (ST-603)
                   Compared to Vehicle in Subjects With Moderate to Severe Dry Eye Syndrome( ST-603-005)
6/07 to 4/08:      XPF2 Study: Bromfenac BID Plus Prednisolone Acetate BID versus Bromfenac BID Plus Prednisolone
                   QID for the Prevention of Cystoid Macular Edema and Retinal Thickening (Principle Investigator)
                   Carlos; Educational Grant provided by Ista Pharmaceuticals)
3/07 to 11/07:     LenstecTM Softec HDTM Posterior Chamber IOL Clinical Study (Phase 3 study); enrollment complete
3/07 to 8/07:      Phase 3 Multicenter, Randomized, Double-Masked, Placebo-Controlled Study of Difluprednate in the
                   Treatment of Inflammation Following Ocular Surgery (Sirion Therapeutics study # ST-601A-002a)
11/06 to 1/08:     I-Stent Trabecular Bypass Micro Stent in Combination with Cataract Surgery in Subjects with Open-
                   Angle Glaucoma, GC-003, Glaukos Corporation (Phase 3 study): Enrollment Complete
10/06 to 1/08:     Efficacy of Topical Cyclosporine Ophthalmic Emulsion for the Prevention and Treatment of Dry Eye
                   Symptoms Following LASIK or Photorefractive Keratectomy: Enrollment Complete
11/06 to 10/07:    LenstecTM TetraFlexTM Accommodating Posterior Chamber IOL Clinical Investigation (IDE
                   G050048); enrollment complete
1//06 to 04/07:    Evaluation of the IOP-Lowering Effect & Tolerability of Bimatoprost 0.03% (Lumigan®) Compared
                   with Travoprost 0.004% (Travatan®) in Patients with Glaucoma or OHTN (Allergan MA-LUM01 study)
9/06 to 12/06:     A Randomized Evaluation of Two Surgical Kits: Gatifloxacin, Ketorolac LS, and Pred Forte Compared
                   with Moxifloxacin, Nepafenac, and EconoPred in Patients Undergoing Cataract Surgery. Complete
8/06 to present:   A Multicenter Study on a Rapid screening tests for detection of HSV in tears; Rapid Pathogens
                   Screening, Inc
7/06-12/06:        A Randomized, Double-Masked Safety and Efficacy Study of FID #109980 Compared to FID #110656
                   in the Treatment of Dry Eye; Phase 3 Dry eye study sponsored by Alcon.
7/06-11/06         Comparison of Topical Xibrom™ vs Acular LS for the Control of Pain, Photophobia, and Discomfort
                   Following PRK; Investigator initiated study, funded by Ista pharmaceuticals
6/06-11/06         Efficacy and Safety of Topical Bromfenac Ophthalmic Solution 0.18% vs. Placebo for Treatment of
                   Ocular Inflammation & Pain and following Cataract Surgery ISTA-BR-CS02 Protocol; Phase 3 study;
                   Ista pharmaceuticals; Study completed
6/06-11/06         A multi-center, randomized, double-masked, parallel clinical trial to evaluate the clinical and microbial
                   efficacy of 0.6% ISV-403 compared to Vigamox in the treatment of bacterial conjunctivitis. Phase 3
                   study; Bausch & Lomb
5/06-4/07          A Multicenter Evaluation of Methods to Reduce Hyperemia Associated with Bimatoprost Therapy for
                   Glaucoma or Ocular Hypertension; (Educational Grant provided by Allergan)
5/06-12/06         Comparison of Bimatoprost 0.03% Monotherapy vs. Dual Therapy with Travoprost 0.004% and Timolol
                   0.5% in Patients with Glaucoma. (Educational Grant provided by Allergan)
5/06-4/07          Brimonidine Purite 0.15% versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
                   (Educational Grant provided by Allergan)
2/06-7/06          Comparison of Pred Forte to Acular & Pred Forte for post cataract surgery inflammation (Allergan);
1/06-4/06          Double-masked study of Acular LS vs Nevanac for pain control following PRK (Educational Grant
                   provided by Allergan);
11/05-3/06         Double-masked study of Acular LS vs Nevanac for pain control following flapless epi-LASIK
                   (Educational Grant provided by Allergan);
10/5 –3/06         Double-masked comparison of Restasis vs Refresh for Patients with Contact Lens Intolerance
                   (Educational Grant provided by Allergan);

                                                           3
                                       William B. Trattler, MD
5/05-6/05            Comparison of Soothe vs Genteal in Patients with Dry Eye due to Computer Vision Syndrome;
                     (Educational Grant provided by Alimera Sciences)
4/04 – 8/05          Clinical Investigator for Alcon Pharmaceuticals in their Phase 3 trial on a new medication for dry eye
4/04 – 9/04          Clinical Investigator for Inspire Pharmaceuticals in their Phase 3 trial on Diquafosol (for dry eye)
1/04 – 5/04          Comparison of the Speed of Epithelial Healing following LASEK (Educational Grant provided by
                     Alcon)
4/02 – 12/05         Deep Lamellar Endothelial Keratoplasty (DLEK) Study Group International Collaborative Study on
                     DLEK as an alternative to Corneal transplants for patients with Pseudophakic Corneal Edema; Study
                     headed by Mark Terry, MD
3/02-7/02            Clinical investigator for Aqueous Pharma LLC Performed clinical study with TeargardTM for patients
                     with evaporative dry eye
11/01-2/05           Clinical Investigator of the Medennium/Ciba Vision Phakic Refractive Lens (PRL) Phase 3 Investigation
                     of Safety and Efficacy for Myopia
6/89-9/89            Summer Research Fellow in Ocular Immunology
                          Mentors:      Scott Cousins, M.D., Assistant Professor, Bascom Palmer Eye Institute
                                        J. Wayne Streilein, M.D., Professor and Chairman, Department of Microbiology &
                                            Immunology, University of Miami School of Medicine
6/87-9/87            Member of Shark Research Team: Participated in research studying shark growth in Bimini, Bahamas,
                     and the diet of young lemon sharks near Little Torch Key (in the Florida Keys)
                          Mentor:           Samuel H. Gruber, Ph.D., School of Marine Science, University of Miami
6/85-9/85            Summer Research Fellow in Ophthalmology
                          Mentor:       Duco I. Hamasaki, Ph.D., Professor, Bascom Palmer Eye Institute




continued on next page




                                                              4
                                    William B. Trattler, MD
PUBLICATIO S

    Journal Articles
              1.   Trattler W, Noecker RJ, Earl ML. A multicentre evaluation of the effect of patient education on
                   acceptance of hyperaemia associated with bimatoprost therapy for glaucoma or ocular hypertension.
                   Adv Ther. 2008 Mar 19. [Epub ahead of print]
              2.   Randleman JB, Trattler WB, Stulting RD. Validation of the Ectasia Risk Score System for preoperative
                   laser in situ keratomileusis screening. AJO. 2008 May;145(5):813-8.
              3.   Krueger RR, Trattler W, Yee R. Introduction to the proceedings of the Sixth International Congress on
                   Advanced Surface Ablation & SBK. J Refract Surg. 2008 Jan;24(1):S55-6
              4.   Caster AI, Trattler W. Corneal ectasia after laser vision correction; Int Ophthalmol Clin. 2008
                   Winter;48(1):73-81.
              5.   Trattler WB, McDonald M; Double-Masked Comparison of Ketorolac Tromethamine 0.4% Versus
                    epafenac Sodium 0.1% for Postoperative Healing Rates and Pain Control in Eyes Undergoing Surface
                   Ablation; Cornea, August 07; 665-669
              6.   Trattler W, Katsev D, Kerney D; Self-reported compliance with topical cyclosporine emulsion 0.05%
                   and onset of the effects of increased tear production as assessed through patient surveys.; Clin
                   Ther.2006 Nov;28(11):1848-56
              7.   Trattler WB, Luchs J, Majmudar P. Elestat (epinastine HCl ophthalmic solution 0.05%) as a therapeutic
                   for allergic conjunctivitis. Int Ophthalmol Clin. 2006 Fall;46(4):87-99.
              8.   Trattler W, Salz JJ. Surface ablation over LASIK flaps. Int Ophthalmol Clin. 2006 Summer;46(3):117-
                   22
              9.   Salz JJ, Trattler W. Pupil size and corneal laser surgery. Curr Opin Ophthalmol. 2006 Aug; 17(4):373-9.
              10. Di Pascuale M, Liu T, Trattler W, Tseng S. Lipid Tear Deficiency in Persistant Dry Eye After Laser in
                  situ Keratomileusis and Treatment Results of ew Eye-Warming Device; JCRS Sep 05; 32 (9)1741-49
              11. Durrie D, Trattler W. A Comparison of Therapeutic Regimens Containing Moxifloxacin 0.5%
                  Ophthalmic Solution and Gatifloxacin 0.3% Ophthalmic Solution for Surgical Prophylaxis in Patients
                  Undergoing LASIK or LASEK. Journal of Ocular Pharmacology & Therapeutics. 21(3)2005:236-41
              12. Trattler W, Whitsett J, Simone, P, Negative Dysphotopsia After Intraocular Lens Implantation
                  Irrespective of Design & Material, Journal of Cataract and Refractive Surgery. 31 (April 2005): 841-844
              13. Salz JJ, Boxer Wachler BS, Holladay JT, Trattler W. ight vision complaints after LASIK
                  Ophthalmology. 2004 Aug;111(8):1620-1; Comment on: Ophthalmology. 2004 Jan;111(1):3-10.
              14. Ta CN, Shine WE, McCulley JP, Pandya A, Trattler W, Norbury JW. Effects of Minocycline on the
                  Ocular Flora of Patients with Acne rosacea or Seborrheic Blepharitis. Cornea. 2003 Aug;22(6):545-8
              15. Cousins S.W., Trattler W.B., and Streilein J.W. Immune Privilege and Suppression of Immunogenic
                  Inflammation in the Anterior Chamber of the Eye. Current Eye Research. 10 (1991): 287-297.
              16. Hamasaki D.I., Trattler W.B., and Hajek A.S. Light O Depresses and LightOFF Enhances the Release
                  of Dopamine from the Cat's Retina. Neuroscience Letters. 68 (1986): 112-116.




                                                           5
                                 William B. Trattler, MD
Abstracts/Posters at National Meetings

          1.   Wachler BB, Trattler W; Ectasia following LASIK with the flap created by a Femtosecond laser;
               American Academy of Ophthalmology Annual Meeting; New Orleans, LA; Nov 12, 2007
          2.   Trattler W, Rapoza P, Peace J, Chu R, Walters T, Stewart, R, Bianca R, Gow J, McNamara T; for the
               Bromfenac Ophthalmic Solution Once Daily Study Group; Integrated Results From Two Phase III
               Clinical Trials of a Once-Daily Bromfenac Ophthalmic Solution for Ocular Surgery; The American
               Academy of Ophthalmology Annual Meeting; New Orleans, LA; Nov 12, 2007
          3.   Trattler W; The Clinical Performance of the Tetraflex Accommodating Posterior Chamber IOL: USFDA
               Multicenter Investigation; The American Academy of Ophthalmology Annual Meeting; New Orleans,
               LA; Nov 12, 2007
          4.   Buznego C, Trattler W; Twelve-Month Analysis of the iStent Trabecular Shunt for the Treatment of
               Primary Open-Angle Glaucoma in Patients Undergoing Phacoemulsification.; 2007 ISRS/AAO Annual
               Regional Meeting; Beijing, China. May 27, 2007
          5.   Tauber S, Trattler W, Luchs J, Majmudar P; A Randomized, Double-Masked, Contralateral Eye Clinical
               Evaluation of Ketorolac 0.4% Versus Nepafenac 0.1% in Photorefractive Keratectomy (PRK) Patients.
               Poster presented at ARVO, May 10, 2007
          6.   Robert J. Noecker, MD; William Trattler, MD; Melissa L. Earl, MPH. Brimonidine Purite 0.15% versus
               Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost; Amerrican Glaucoma Society; San
               Francisco, CA; February 2007
          7.   Trattler W, Stulting D, Abad J, Speaker M, Gold J, Nasser R, Claringbold T, Majmudar P, Luchs J,
               Tauber , S, Binder P; Delayed Epithelial Healing With Nepafenac 0.1% Ophthalmic Suspension;
               Presented at: 2006 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Asia
               Pacific Academy of Ophthalmology (APAO); November 11-14, 2006; Las Vegas, NV.
          8.   Wittpenn J, Silverstein S, Hunkeler J, Schedter B, Price F, Chu R, Wallace B, Trattler W, Solomon K,
               Donnenfeld E, Kenyon K, Roberts C. A masked comparison of Acular LS plus steroid versus steroid
               alone for the prevention of macular leakage in cataract patients. Presented at: 2006 Joint Meeting of the
               American Academy of Ophthalmology (AAO) and the Asia Pacific Academy of Ophthalmology
               (APAO); November 11-14, 2006; Las Vegas, NV.
          9.   Trattler W, Katzev D, Kerney D. Self-Reported Compliance with Topical Cyclosporine Emulstion
               0.05% and onset of Effects of Increased Tear Production. Abstract ARVO May 2006
          10. McDonald MB, Trattler W. Double-Masked Comparison of Ketorolac Tromethamine 0.4% versus
              Nepafenac Sodium 0.1% for Postoperative Healing Rates and Pain Control in Eyes Undergoing Surface
              Ablation. ARVO April 30, 2006.
          11. J.F. McDonnell, D.A. Montgomery, W. Trattler, B. Larson, and T. Shivan; Scotopic Pupil Size and the
              Level of Pre–Operative Myopia as They Relate to the Starburst Phenomenon Following LASER Vision
              Correction; Invest. Ophthalmol. Vis. Sci. 2006 47: E-Abstract 53.
          12. M. Yen, G. Alexandrakis, M. Shuler, W. Trattler, & E. Ysasaga, Outcomes of Initial Resident Cataract
              Surgery; Comparison of Incisional techniques. The American Society of Cataract and Refractive
              Surgery Annual Meeting, May 2000, Boston, MA
          13. M. Shuler, G. Alexandrakis, W. Trattler, M. Yen, & E. Ysasaga, Effect of Cataract Incision Technique
              on Postoperative Astigmatism. The American Society of Cataract and Refractive Surgery Annual
               Meeting, May 2000, Boston, MA
          14. E. Ysasaga, G. Alexandrakis, M. Shuler, W. Trattler, & M. Yen, Accuracy of Intraocular Lens
              Calculations by Resident Surgeons. The American Society of Cataract and Refractive Surgery Annual
              Meeting, May ‘00, Boston, MA
          15. S. Goldstein, S. Orlin, M. Maguire, W. Trattler, S. Levy, M. Sulewski, Long Term Survival of
              Penetrating Keratoplasty. The Association for Research in Vision and Ophthalmology (ARVO), Annual
              Spring Meeting, April 2000, Ft. Lauderdale, FL
          16. McCulley, J.P., Shine, W.E., and Trattler, W. Effects of Minocycline on the Ocular Flora of Patients
              with Acne Rosacea & Seborrheic Blepharitis. Inv Ophthalmology Vis Sci. 40 (supp): p. 691, 1999




                                                        6
                                William B. Trattler, MD
         17. Trattler W.B., Streilein J.W., and Cousins S.W. The Anterior Chamber is Resistant to Delayed
             Hypersensitivity Unless Immune Privilege is Abrogated by Gamma Interferon. Inv Ophthalmology Vis
             Sci. 31 (supp): 214, 1990.

Textbooks
               Trattler, W. and Gladwin, M. Clinical Microbiology Made Ridiculously Simple. A 260 pagetextbook;
                   “A brief, clear, thorough, and highly enjoyable approach to clinical microbiology brimming with
                   mnemonics, humor, summary charts, and illustrations.” Now in Edition 3
               Friedman,N., Kaiser, P., Trattler, W. Review of Ophthalmology. Elsevier Saunders; October 2004 A 390
                   page textbook for detailed review of ophthalmology topics.
               Goldberg, S and Trattler, W. Ophthalmology Made Ridiculously Simple. Interactive Edition.
                   Medmaster. November 2004. 82 page introductory book to ophthalmology topics, with CD ROM
                   atlas of clinical photos

Chapters in Textbooks:

               Salz J & Trattler W: Preoperative Evaluation for Refractive Surgery, Cornea, 2004; pages 1897-1908
               Trattler W & Salz J; Preoperative Evaluation of the Prospective Hyperopic Refractive Surgery Patient,
                     Surgery For Hyperopia; November 2003; pages 44 -54

Published Articles/Interviews in Ophthalmology Journals ( on Peer-Reviewed)

         1.    When to avoid PRK; EyeWorld; May 2008
         2.    Industry trends toward improved diagnostic technology; EyeWorld;April 2008
         3.    Comparing surgery results EyeWorld;April 2008
         4.    Connecting diabetes and myopia; EyeWorld;April 2008
         5.    Calculating ectasia risk factors; EyeWorld March 2008
         6.    Virgin corneas after E-PRK; EyeWorld; March 2008
         7.    Cataract surgery innovations; Advances in techniques; EyeWorld; March 2008
         8.    Results for LASIK and phakic IOL patients compared ; EyeWorld; March 2008
         9.    Incorrectly diagnosing keratoconus; EyeWorld; March 2008
         10.    ew technique for retreatments; EyeWorld; March 2008
         11. Effectively treating ocular allergies; EyeWorld; March 2008
         12. Promising topography research; EyeWorld; March 2008
         13. SF6 effective in managing corneal hydrops? EyeWorld; March 2008
         14. Cataract surgery innovations: Femtosecond laser incision techniques; EyeWorld; March 2008
         15. EyeMail Insights: Pterygium and mitomycin C; EyeWorld; March 2008
         16. HOAs and fantastic vision not mutually exclusive; EyeWorld; February 2008
         17. Oblique viewing could affect refraction; EyeWorld; February 2008
         18. The Thick and Thin of Ectasia; Eyenet Magazine; January 2008
         19. Dynamics of coma development; Eyeworld; Jan 2008
         20. Donnenfeld, Trattler, Buznego; The Relationship Between Dry Eye and Cataract Surgery: Pre-existing
             dry eye can affect IOL calculations, and dry-eye induced by cataract surgery can affect visual outcomes.
             Review of Ophthalmology, November 2007
         21. Collagen cross-linking after PRK; EyeWorld; November 2007
         22. Seeing red over the refraction charge: EyeWorld; November 2007


                                                       7
                       William B. Trattler, MD
23. Challenging Cataract Cases: The most challenging cataract cases: EyeWorld; October 2007
24. Challenging Cataract Cases: Capsular rupture … the new solution; EyeWorld; October 2007
25. PMD or Keratoconus? Eyeworld; September 2007
26. Trattler, Buznego; Pearls for Success With Presbyopia-Correcting IOLs; The authors provide their
    pre-, intra-, and postoperative tips and tricks for improved outcomes ; Cataract & Refractive Surgery
    Today; Sept 2007
27. Point/Counterpoint: Is Corneal Thickness a Risk Factor for Post-LASIK Ectasia? ; Cataract &
    Refractive Surgery Today; September 2007
28. To diamond cut or not; Eyeworld; September 2007
29. Delayed Epithelial Healing After Surface Ablation
30. Dry Eye Gets Some Respect; Eyenet Magazine; August 2007
31. Clinical Update: Eye on Eye Medicine, Part Fou; World Wide Medicine: When Patients Surf the Web;
    Eyenet Magazine; August 2007
32. Preliminary analyses point to efficacy of once-daily SAID: ew bromfenec ophthalmic solution can
    control pain, inflammation after cataract surgery; Ophthalmology Times; July 2007
33. Case study: Accidental corneal transplant dehiscence; Physicians discuss how to prevent infection
    when the anterior segment is open and the cornea is contaminated; Ocular Surgery News, June 2007
34. Eye drop offers action at surface, cellular levels: Could be 1st-line therapy for dry eye and in
    conjunction with topical cyclosporine; Ophthalmology Times; May 2007
35. Incomplete blinking may be connected to keratopathy after LASIK; EyeWold. May 2007
36. Microbial keratisis threatens contact lens wearers; EyeWold. May 2007
37. Ocular infection linked to IBD; EyeWorld. May 2007
38. Haze treatment versus haze prevention; EyeWorld. May 2007
39. Orthokeratology: commend or condemn? EyeWorld. May 2007
40. Minimizing ight Vision Problems in Patients with Large Pupils; Refractive Eye Care; May 2007
41. Panel examines SAID use in surface ablation procedures, part 2 (Lindstrom D; Durrie D; Gayton J;
    O’Brien T; Trattler W); Ocular Surgery News; April 2007
42. Panel explores clinical considerations of SAID use in surface ablation patients, part 1 (Lindstrom D;
    Durrie D; Gayton J; O’Brien T; Trattler W); Ocular Surgery News; April 2007
43. Patients with corneal infiltrates; This month’s Corneal Health column focuses on identifying cases of
    infectious infiltrations; Ocular Surgery News; April 2007
44. EyeMail Insights: Standards for a one-eyed cataract surgery candidate; EyeWorld; April 2007
45. Ocular Allergies Common, Causes are not; EyeWorld; March 2007
46. Minimizing Postoperative Discomfort; Cataract and Refractive Surgery Today; Feb 2007
47. Use of surface ablation increasing; Experts debate its future; Ocular Surgery News. Jan 1, 2007
48.    SAID regimen important in perioperative care of laser surface ablation patients: ; Ocular Surgery
      News. Jan 1, 2007
49. Advanced surface ablation finding increasing role in refractive surgery, surgeon says; OSN Supersite
    Breaking News 11/22/06
50. Treatment for Patients with Dry Eye Pre- & Postop; Ophthalmology Management; Dec 2006
51. Surgeon: Pain control key to maximizing surface ablation outcomes; Ocular Surgery News; Nov 15, 06
52. Surgeon: Pain control key to maximizing surface ablation outcomes; OSN Supersite Top Story 10/17/06
53. Point/Counterpoint:LASIK vs Surface Ablation; Cataract & Refractive Surgery Today; Oct 2006


                                              8
                     William B. Trattler, MD
54. Surface Ablation Prophlactic: Vitamin C or Mitomcin C; Ophthalmology Management, Sept 2006
55. The Role of SAIDs and Their Surgical Applications; Surgical applications for SAIDs; Ocular Surgery
    News Monograph; Sept 1, 2006
56. Surface Ablation for Keratoconus. Cataract & Refractive Surgery Today, August 2006.
57. Slade, Springs C; Trattler W, Woodhams T: Classifying Keratoconus: Surgeons discuss how they define
    mild keratoconus, keratoconus, and forme fruste keratoconus, and they share their top indices for
    distinguishing between the three corneal states. Cataract & Refractive Surgery Today, August 2006.
58. Doane J, Binder P. Majmudar P, Probst L, Slade S, Trattler W: What is your Diagnosis? Surgeons
    discuss their analyses of various topographies of possibly keratoconus cases and converse about their
    treatment recommendations. Cataract & Refractive Surgery Today, August 2006.
59. Aggressive Treatment of Post-LASIK Dry eye; Ophthalmology Management; July 2006
60. Post-LASIK Dry Eye; Case Presentation and Answers: Cataract & Refractive Surgery Today; June 2006
61. Experience with Acuvue® Oasys™ as a Bandage Lens, Refractive Eye Care, June 2006
62. Letter to the Editor; Response to Terry O’Brien’s question on evanac and delayed epithelial Healing;
    Cataract & Refractive Surgery Today, June 2006
63. In hands of experts, surface ablation has many variations; Leading surgeons shared their surface
    ablation surgical techniques & explain why they perform the procedure the way they do. OSN May ‘06
64. Letter to the Editor; Response to Johnny Gayton’s question on evanac and delayed epithelial Healing;
    Cataract & Refractive Surgery today, June 2006
65. Topical SAIDS for Pain And inflammation; Review of Ophthalmology, May 2006
66. LASIK Buttonhole After Cataract Surgery: Case Presentation and Answers; Cataract & Refractive
    Surgery Today; April 2006
67. Ketorolac vs. epafenac Study: Toxicity Delays Epithelial Healing in epafenac-Treated Eyes; Eye
    World Supplement, April 2006
68.    SAIDs and Delayed Healing; Cataract & Refractive Surgery Today; March 2006
69. Are Surface Enhancements safe? Review of Ophthalmology, March 2006
70. Breaking ew Ground: Lasers in Keratoconus; Surgeons are taking a look at certain kinds of refractive
    surgery in patients others might not operate on. Review of Ophthalmology, March 2006
71. The Role of SAIDS following Surface Ablation, Ocular Surgery News Supplement, Feb 2006
72. Enhancement Following Epi-LASIK; Cataract & Refractive Surgery Today; Feb 2006
73. Roundtable Participants Discuss Advanced Surface Ablation; Primary Care Optometry News; Jan 2006
74. Round Table Discussion: Surface Ablation; Ocular Surgery News, October 2005
75. Known Risk Factors for Ectasia: What do we know so far? Cataract & Refractive Surgery Today, Oct‘05
76. Volpicelli M, Trattler W; Epi-LASIK: The Procedure, Pain Management and Patient results;
    Ophtalmology Management Sept 2005
77. Mast Cell Stabalizers Ideal For Giant Pappillary Conjunctivitis; Ophthalmology Times, September 2005
78. Pupil Size, Accommodation Among Hot Summer Refractive Topics; EyeWorld, September, 2005
79. Can Large Pupils Lead to Poor Vision After LASIK; EyeWorld, September, 2005
80. Adam Crawford; Retired Physician Writes “Simple” Books; EyeWorld, September 2005
81. The Role of Lipid-Containing Artificial Tears in Refractive Surgery; Supplement, Refractive Eyecare;
      June 2005
82. David Meadows, Ph.D., William Trattler, MD, Jeffrey Gilbard, MD, Peter Simmons, Ph.D. Science
    Behind Today’s Artificial Tears; The science and mechanism of action behind today’s most unique
    formulations. Ophthalmology Management, June 2005


                                            9
                                    William B. Trattler, MD
              83. Lose the Pain, But Keep the Gain: Getting good results with refractive surface procedures doesn't have
                  to Hurt.; Review of Ophthalmology; June 2005
              84.    ew intracanalicular punctum plug relieves dry eye; Ophthalmology Times May15, 2007
              85. Refractive Surgery: Insight on Ectasia; Review of Ophthalmology, March 2005
              86. Helpful Ways to Prevent and Treat Ectasia; EyeWorld, March, 2005
              87. W. Trattler, MD. LASEK Wound Healing with Fourth Generation Fluoroquinolones. EyeWorld
                  Supplement, Feb. 2005
              88. Study Finds Correlation between night vision troubles, larger pupils; EyeWorld, February 2005
              89. Are Surface Enhancements Safe? Review of Ophthalmology; Nov. 2004
              90. W. Trattler, MD & Dan Durrie, MD. ewer Fluoroquinolones preferred antimicrobial prophylaxis.
                  Patients undergoing excimer laser refractive procedures can be assured of broad-spectrum coverage.
                  Ophthalmology Times; November 1, 2004. page 21.
              91. Fourth Generation Fluoroquinolones’s effect on LASEK. EyeWorld Supplement Oct. ‘04
              92. Fluoroquinolone Choice Does Not Affect Wound Healing in LASEK, Refractive Eye Care,Oct 2004
              93. Learning From Our Refractive Surgery Patients; Refractive Eye Care; July 2004
              94. Combination Therapies for Dry Eye Patient, Cataract & Refractive Surgery Today Feb‘04
              95. Surface ablation pain-control techniques continue to evolve, Eyeworld, December 2003
              96. W Trattler, MD & Jodi Luchs, MD Mast Cell Stabalizers Help with Chronic Allergic Symptoms,
                    Ophthalmology Times, September 2003
              97. Understanding Postsurgical Haze, Cataract & Refractive Surgery Today, March 2003
              98. Can Surface Ablation Be Used to Enhance or Complete LASIK Procedures?, Refractive Eye Care, Nov
                  2002
              99. Websites to Watch, Review of Ophthalmology, January 2001
              100. D. Ruriani. Complicated Cases: Creatively Managing Microstriae. Eye World. July 2000
              101. LASIK and Dry Eye – The Connection; Case Management for Improved Outcomes and Patient
                    Satisfaction. Ophthalmology Management Supplement, April 2000
              102. What to Know Before You Launch Your Website, Review of Ophthalmology, March 2000
              103. Complicated Cases: Superficial microkeratome pass. EyeWorld, Feb 2000
              104. T. Henderson, MD, W. Hill, MD, William Trattler, MD, et al. Complicated CasesLensectomy and IOL
                   implantation with Marfan’s habitus. Eye World Jan. 2000
              105. W. Bethke, Patients and the Web: The Psychology of the Search. Review of Ophthalmology, Dec 1999
              106. R. Fellman, S. Ullman, W. Trattler, et al. Complicated Cases: Cataract extraction for pseudoexfoliation
                   with phacodonesis. Eye World. November 1999

     Chapters in Online Textbooks
               Trattler, W. & Clark, W. Macular Corneal Dystrophy. Emedicine.com, June 2000
              Trattler, W. & Clark, W. Granular Corneal Dystrophy. Emedicine.com, July 2000
              Trattler, W. & Clark, W. Lattice Corneal Dystrophy. Emedicine.com, June 2000
              Clark, W, Kaiser, P & Trattler, W. Postoperative Endophthalmitis. Emedicine.com, June 2000

SCIE TIFIC MEETI GS

  1. Meeting Organizer with Ronald Krueger, MD, Richard Yee, MD, & Dan Durie: The Seventh International Congress
      on Surface Ablation and Sub Bowman's Keratomileusis; Ft. Lauderdale, FL, April 26, 2008

                                                          10
                                     William B. Trattler, MD
  2. Meeting Organizer with Ronald Krueger, MD, Richard Yee, MD, & Dan Durie: The Sixth International Congress on
      Surface Ablation and Sub Bowman's Keratomileusis; Ft. Lauderdale, FL, May 5, 2007

  3. Meeting Organizer with Ronald Krueger, MD, Richard Yee, MD, The Fifth International Congress on Epi-LASIK &
      LASEK, & Advanced Surface Ablation; London, UK; Sept 8, 2006

  4. Meeting Organizer with Ronald Krueger, MD, Richard Yee, MD, & Massimo Camellin, MD, The Fourth International
      Congress on Epi-LASIK & LASEK, & Advanced Surface Ablation; April 2005, Ft. Lauderdale, FL

PRESE TATIO S AT REGIO AL OR ATIO AL MEETI GS

  1. Risk Factors for Post-LASIK Ectasia, and Corneal Collagen Cross-linking; Virginia Society of Ophthalmology;
      Leesburg, VA; June 6th, 2008

  2. Preoperative Evaluation of Presbyopia Correcting IOL Patients; Superior Outcomes through Refractive and Cataract
      Education (SOURCE); May 31, 2008; Houston, TX

  3. Dosing and Comparison of Topical NSAIDS; Superior Outcomes through Refractive and Cataract Education
      (SOURCE); May 31, 2008; Houston, TX

  4. What would you do (Presentation of Suprachoroidal Hemorrhage during IOL positioning) Superior Outcomes through
      Refractive and Cataract Education (SOURCE); May 31, 2008; Houston, TX

  5. Why Corneal thickness does not predict ectasia risk; Symposium on Laser Refractive Surgery; 13th Annual Joint
      Meeting Of OSN, SOI & AICCER; May 10, 2008; Naples, Italy

  6. The Case for SBK as the Ideal Procedure; Symposium on Laser Refractive Surgery; 13th Annual Joint Meeting Of
      OSN, SOI & AICCER; May 10, 2008; Naples, Italy

  7. Ocular Surface Disease and Osmoprotection; Symposium on Laser Refractive Surgery; 13th Annual Joint Meeting Of
      OSN, SOI & AICCER; May 10, 2008; Naples, Italy

  8. Transitioning from Surface Ablation Back to LASIK; iLASIK Symposium; Naples, Italy; May 9, 2008

  9. Trattler AIRS A PRK practice One year after Intralase; Aspen Invitational Refractive Symposium; Aspen, CO; March
      11, 2008

  10. Pearls for Reducing Ectasia Risk; Winter Corneal Refractive Invitational Summit; Telluride, CO; February 25th, 2008

  11. Surface Ablation 2008; Aspen Corneal Society Meeting; February 20th, 2008

  12. Risk Factors for Ectasia; Aspen Corneal Society Meeting; February 18th, 2008

  13. PRK vs. LASIK vs. Epi-LASIK: Is There a difference; Royal Hawaiian Eye Meeting; January 25, 2008

  14. Inflammation and Pain Control for your IOL Patients who need Laser Vision Correction; Symposium at the Royal
       Hawaiian Eye; January 20, 2008

  15. Optimizing results of Presbyopic IOL Surgery; American Academy of Ophthalmology; New Orleans, LA; Nov 13, ‘07

  16. Medications to Maximize Surface Ablation; Part of ISRS Symposium entitled: Now That You Have the Tools, How Do
       You Get the Best Results? American Academy of Ophthalmology; New Orleans, LA; Nov 12, ‘07

  17. Update on Nevanac Toxicity Issues with Surface Ablation; PRK, Epi-LASIK and LASIK nightmares; Complications in
       laser vision correction; American Academy of Ophthalmology; New Orleans, LA; Nov 11, ‘07

  18. Surface Ablation Round Table Round-Up; Refractive Subspecialty Day; American Academy of Ophthalmology; New
       Orleans, LA; Nov 9, ‘07


                                                           11
                                  William B. Trattler, MD
19. PRK Nomograms; Refractive Subspecialty Day; American Academy of Ophthalmology; New Orleans, LA; Nov 9, ‘07

20. Patient Selection for SBK vs Surface Ablation; Intralase Users Group Meeting; New Orleans, LA; November 8, 2007

21. The Case for Sub-Bowman's Keratomileusis as the Ideal Keratorefractive Procedure; OSN New York; October 13, ‘07

22. Interpretation of Topography Preoperatively; Refractive IOL Symposium; Las Vegas, NV; September 30, ‘07

23. Preoperative Evaluation of the Presbyopic IOL Patient; SOURCE (Superior Outcomes through Refractive & Cataract
     Education), Manhattan, NY, Sept 15, 2007

24. Dosing and Comparison of NSAIDS; SOURCE (Superior Outcomes through Refractive & Cataract Education),
     Manhattan, NY, Sept 15, 2007

25. Laser Correction of Astigmatism vs. LRIs or Toric IOLs; SOURCE (Superior Outcomes through Refractive & Cataract
     Education), Manhattan, NY, Sept 15, 2007

26. Complications Panel: What would you do (case of Suprachoridal hemorrhage during toric IOL insertiont; SOURCE
     (Superior Outcomes through Refractive & Cataract Education), Manhattan, NY, Sept 15, 2007

27. Case presentation: Is 12 Seconds Enough? ASCRS Summer Refractive Congress, Carlsbad, CA, August 4, 2007

28. Case presentation: To Lift or Not to Lift? ASCRS Summer Refractive Congress, Carlsbad, CA, August 4, 2007

29. Case presentation: Irregular Astigmatism and Multifocal IOLs; ASCRS Summer Refractive Congress, Carlsbad, CA,
     August 4, 2007

30. Debating Today’s Refractive Controversies: Surface Ablation vs. Thin Flap LASIK; Aspen Summer Refractive
     Congress; July 29th, 2007

31. Using and Choosing NSAIDs; Corneal Health Market Guidance Program; Key Biscayne, FL June 24, 2007

32. PRK, LASEK and Epi-LASIK: Is There a Difference? Ocular Surgery News Las Vegas Symposium; June 8, 2007

33. Surface versus Lamellar Excimer Treatments; Ocular Surgery News Las Vegas Symposium; June 8, 2007

34. Risk Factors for Ectasia; Tristate Ophthalmology Congress; Las Vegas, NV; May 19, 2007

35. Optimizing Results with Surface Ablation; Tristate Ophthalmology Congress; Las Vegas, NV; May 19, 2007

36. Trattler W, Tauber S, Luchs J, Majmudar P; Randomized Masked Contralateral-Eye Comparison of Ketorolac 0.4%
     Versus Nepafenac 0.1% in Patients Having PRK; American Society of Cataract & Refractive Surgery; San Diego, CA;
     May 1, 2007

37. Sher N, Golben M, Bond W, Trattler W, Tauber; S; Randomized Trial of Topical Bromfenac 0.09% Versus Ketorolac
     0.4% for Control of Post-PRK Pain and Discomfort; American Society of Cataract & Refractive Surgery; San Diego,
     CA; May 1, 2007

38. Medicolegal Issues in Refractive Surgery; American Society of Cataract & Refractive Surgery; San Diego, CA; April
     29, 2007

39. Vision and Sports: Sports Ophthalmology Society of the Americas; American Society of Cataract & Refractive
    Surgery; San Diego, CA; May 1, 2007

40. Surface Ablation (PTK, PRK, LASEK) for Complicated Post-Refractive Surgery and Post-Surgical Eyes; American
     Society of Cataract & Refractive Surgery; San Diego, CA; May 1, 2007

41. Advanced Surface Ablation: Pearls for Perfecting Preop and Postop Care from Pioneers and Pundits; American Society
     of Cataract & Refractive Surgery; San Diego, CA; April 29, 2007


                                                        12
                                   William B. Trattler, MD
42. Controversies in Refractive Surgery; American Society of Cataract & Refractive Surgery; San Diego, CA; April 28,
     2007

43. Identifying Risk Factors for Ectasia: A practical Approach; American Society of Cataract & Refractive Surgery; San
     Diego, CA; April 28, 2007

44. Update on Dry Eye; Sixth Annual Pacific Eye Insitute Annual Meeting; San Francisco, CA; March 23rd, 2007

45. Surface Management in PRK and LASIK; Aspen Invitational Refractive Symposium; March 5, 2007

46. Presbyopic IOLs in 2007, Aspen Cornea Society, Feb 23, 2007

47. Risk Factors for Ectasia; Aspen Corneal Society; Feb 21, 2007

48. Surface Ablation 2007; Aspen Corneal Society; Feb 19, 2007

49. Optive; Allergan Speaker’s Training, February 2, 2007

50. Optive Round Table; Allergan National Sales Meeting, Anaheim, CA; January 22, 2007

51. Risk Factors for Ectasia; Bascom Palmer’s Inter-American Course in Clinical Ophthalmology; Miami, FL; Nov 20,2006

52. Update on Surface Ablation; Bascom Palmer’s Inter-American Course; Miami, FL; Nov 20, 2006

53. Epi-LASIK Complications; New Refractive Techniques and LASIK Complications Course; The American Academy of
     Ophthalmology Annual Meeting; Las Vegas, NV; November 14, 2006

54. Case Report: Two cases of Ectasia Following LASIK; PRK, EpiLASIK, LASEK, and LASIK Nightmares Course; The
     American Academy of Ophthalmology Annual Meeting; Las Vegas, NV; November 13, 2006

55. Evolving Concepts of Topical Antihistamines/Mast Cell Stabilizers; Venetian Hotel, Las Vegas, NV; Nov 11, 2006

56. Pain Control in Epi-LASIK and PRK; Ocular Surgery News 2006 New York Symposium; Manhattan, NY; October 14,
     2006

57. Acrysof Toric IOL, SOURCE (Superior Outcomes through Refractive & Cataract Education), New Port Beach, CA,
     Sept 30, 2006

58. Dry Eye in Cataract & Refractive Surgery, SOURCE, New Port Beach, CA; Sept 30 2006

59. Pain control with Surface Ablation, SOURCE, New Port Beach, CA; Sept 30 2006

60. Managing Postoperative Issues in Restor Patients, SOURCE, New Port Beach, CA; Sept 30 2006

61. Acrysof Aspheric IOL and Micro-Coaxial Phacoemulsification, SOURCE, New Port Beach, CA; Sept 30 2006

62. Managing Post-LASIK Dry Eye in Patients with Iatrogenic Ectasia. ASCRS Summer Refractive Congress; Boston,
     August 2006

63. Case Report: Double Trouble in the Laser Suite: Report of 2 cases of Iatrogenic Ectasia on the Same Operating Day.
     ASCRS Summer Refractive Congress; Boston, August 2006

64. Advanced Surface Ablation; New Horizons in Ophthalmology; Aspen, CO; July 2006

65. Risk Factors For Ectasia; New Horizons in Ophthalmology; Aspen, CO; July 2006

66. Custom Enhancements; Aspen Advanced Refractive Surgery Congress; Aspen, CO; July 2006

67. Optimizing Cataract & Refractive Surgery Outcomes; OSN Las Vegas 2006 Improving Your Odds;
    June 9, 2006, Las Vegas, NV

                                                            13
                                   William B. Trattler, MD
68. Advanced Surface Ablation; OSN Las Vegas 2006 Improving Your Odds; June 9, 2006, Las Vegas, NV

69. The Role of an Artificial Tear in the Treatment of Dry Eye; Evolution in Anterior Segment Therapeutics, Tuscon, AZ;
    May 21. 2006

70. Optimizing Outcomes in Refractive Surgery; Evolution in Anterior Segment Therapeutics, Tuscon, AZ; May 21. 2006

71. Optimizing Results in Cataract & Refractive Surgery; 90th Clinical Assembly of the American Osteopathic Colleges
    of Ophthalmology & Otolaryngology Foundation; May 4, 2006, Orlando, FL

72. Topical SAIDs and Surface Ablation; 15th Anniversary VISTA Scientific Conference; April 30, 2006

73. Comparing Ophthalmic onsteroidal Anti-inflammatory Drugs; Evolution in Anterior Segment Therapeutics,
     Aventura, FL April 1, 2006

74. The Role of an Artificial Tear in the Treatment of Dry Eye; Evolution in Anterior Segment Therapeutics, Aventura, FL
     April 1, 2006

75. Risk Factors for Ectasia, The American Society of Cataract & Refractive Surgery Annual Meeting, March 20, 2006,
    San Francisco, CA

76. Medical-legal Issues in Refractive Surgery, The American Society of Cataract & Refractive Surgery Annual Meeting,
    March 20, 2006, San Francisco, CA

77. Pre- and Post-operative Care of Epi-LASIK Patients; at the Norwood Booth, The American Society of Cataract &
    Refractive Surgery Annual Meeting, March 20, 2006, San Francisco, CA

78. Late Presentation of Diffuse Lamellar Keratitis in LASIK Patients; The American Society of Cataract & Refractive
    Surgery Annual Meeting, March 19, 2006, San Francisco, CA

79. Not all Artificial Tears are the Same; at the Allergan Booth; The American Society of Cataract & Refractive Surgery
     Annual Meeting, March 19, 2006, San Francisco, CA

80. Surface Ablation For Complicated Eyes, The American Society of Cataract & Refractive Surgery Annual Meeting,
    March 18, 2006, San Francisco, CA

81. Delayed Healing following evanac in Epi-LASIK Patients; Aspen Invitational Refractive Symposium; March 2006

82. Wavefront-guided LASEK to Enhance Previous LASIK; Aspen Cornea Society; February 2006

83. Risk Factors for Ectasia; Aspen Cornea Society; February 2006

84. Update on Advanced Surface Ablation: Epi-LASIK, LASEK and PRK; Aspen Cornea Society; February 2006

85. An Update on Dry Eye & Restasis; Inspire Speakers Training, January 2006 Las Vegas

86. PRK & LASEK to Enhance Previous LASEK, Hawaiian Eye Meeting, Jan 2006, Maui, HI

87. Epi-LASIK & Advanced Surface Ablation Update; Florida Society of Ophthalmology, Dec 2005, Boca Raton, FL

88. Epi-LASIK Skills Transfer Course; October 13, 2005; Chicago, IL

89. Course Instructor, Phacoemulsification Lab for Ophthalmology Residents, The American Academy of Ophthalmology
    Annual Meeting, October 2005, Chicago, IL

90. Epi-LASIK Skills Transfer Course; August 20, 2005; Boston, MA

91. Does Pupil Size matter? Cornea Society & Paton Society Federated Scientific Session; Saturday, October 15, 2005
     Chicago, Illinois

                                                         14
                                   William B. Trattler, MD
92. LASEK to Enhance Previous LASIK; ASCRS Summer Refractive Congress; August 2005, Seattle, WA

93. Does Pupil Size Matter? ASCRS Summer Refractive Congress; August 2005, Seattle, WA

94. W. Trattler, B. Larson; Risk Factors For Nighttime Vision Problems After LASIK and LASEK; The Fourth
   International Congress on Epi-LASIK & LASEK, and Advanced Surface Ablation; April 2005, Ft. Lauderdale, FL

95. W. Trattler, R. Epstein, D. Hardten, B. Boxer Wachler, P. Amoils, M. Swanson, & M. Smolek; Ectasia: Risk Factors
   & Treatment Options; The American Society of Cataract & Refractive Surgery Annual Meeting, April ‘05,
   Washington D.C.

96. W. Trattler, J. Salz, J. Holladay, B. Boxer Wachler, & S. Brown; Blinded By The Light; The Pupil in Refractive
   Surgery. The American Society of Cataract & Refractive Surgery Annual Meeting, April ‘05, Washington D.C.

97. W. Trattler, N. Sher, W. Zeller; Medicolegal Issues in Refractive Surgery; The American Society of Cataract &
   Refractive Surgery Annual Meeting, April ‘05, Washington D.C.

98. W. Trattler; Surface Ablation (PTK. PRK & LASEK) For Complicated Eyes; The American Society of Cataract &
   Refractive Surgery Annual Meeting, April ‘05, Washington D.C.

99. W. Trattler, B. Larson; Risk Factors For ighttime Vision Problems After LASIK and LASEK; The American
   Society of Cataract & Refractive Surgery Annual Meeting, April ‘05, Washington D.C.

100. Allergy Update: Review of Conjunctival Allergen Challenge Studies For Allergic Conjunctivitis; Inspire Speaker
   Training; Jacksonville, FL Feb 26-27, 2005

101. W. Trattler, MD, B. Larson, MD; Risk Factors for Starburst Phenomena in Refractive Surgery Patients;
   Aspen Corneal Society Meeting, Aspen, CO Feb 22, 2005

102. Update on Surface Ablation; Aspen Corneal Society Meeting, Aspen, CO Feb 21, 2005

103. W. Trattler, MD, B. Larson, MD: Risk Factors for ight Time Vision Phenomena; Cornea Society Meeting,
   Nov. 2004; New Orleans, LA

104. Course Instructor, Phacoemulsification Lab for Ophthalmology Residents, The American Academy of Ophthalmology
   Annual Meeting, November 2004, New Orleans, LA

105. Update on PRK and LASEK, Florida Society of Ophthalmology Refractive Surgery Symposium, Aug 04, Orlando, FL

106. W. Trattler, M. Smolek, D. Hardten, R. Krueger. D. Reinstein, P. Amoils, J. Hiatt, Pearls to Avoid Post-LASIK
   Ectasia; The American Society of Cataract & Refractive Surgery Annual Meeting, May ‘04, San Diego, CA

107. W. Trattler, D.Azar, P Majmudar., P Amoils; Update on LASEK & Advanced Surface ablation; The American
   Society of Cataract & Refractive Surgery Annual Meeting, May 2004, San Diego, CA

108. PRK/LASEK to enhance Previous LASIK; The American Society of Cataract & Refractive Surgery Annual Meeting,
   May 2004, San Diego, CA

109. C. Quinn, W. Trattler, Late Presentations of Diffuse Lamellar Keratitis Following Minor Trauma; The American
   Society of Cataract & Refractive Surgery Annual Meeting, May 2004, San Diego, CA

110. An Update on LASIK Complications; 88th Clinical Assembly of the American Osteopathic Colleges of Ophthalmology
    & Otolaryngology Foundation; April 23, 2004, Miami, FL

111. PRK & LASEK to Enhance Previous LASEK; The 3rd International Congress on LASEK & Epi- LASEK; March
    2004, Houston, TX

112. Haze and Pain Control with PRK & LASEK; The Aspen Corneal Society Meeting; Feb 2004


                                                         15
                                       William B. Trattler, MD
    113. PRK & LASEK over LASIK Flaps; The Aspen Corneal Society Meeting; Feb 2004

    114. W. Trattler, MD, Panel Member, LASEK Course; The American Academy of Ophthalmology Annual Meeting
       November 2003, Anaheim, CA

    115. Course Instructor, Phacoemulsification Lab for Ophthalmology Residents, The American Academy of Ophthalmology
       Annual Meeting, November 2003, Anaheim, CA

    116. Course faculty, Medical legal Issues in Refractive Surgery, The American Society of Cataract and Refractive Surgery
         Annual Meeting, April 14, 2003, San Francisco, CA

    117. Course participant, LASEK Course, The American Society of Cataract and Refractive Surgery Annual Meeting, April
        14 2003, San Francisco, CA

    118. Surface ablation over LASIK Flaps, The American Society of Cataract and Refractive Surgery Annual Meeting, April
        15, 2003, San Francisco, CA

    119. Surface Ablation over LASIK Flaps, The Aspen Corneal Society Meeting; Feb. 2003

    120. Course Instructor, Phacoemulsification Lab for Ophthalmology Residents, The American Academy of Ophthalmology
       Annual Meeting, October 2002, Orlando, FL

    121. Surface Ablation over LASIK Flaps; The Florida Society of Ophthalmology Annual Meeting; June 2002, Miami, FL

    122. Course Instructor, Phacoemulsification Lab for Ophthalmology Residents, The American Academy of Ophthalmology
       Annual Meeting, November 2001, New Orleans, LA

    123. Internet Marketing and Website Development. The American Academy of Ophthalmology Annual Meeting,
        November 2001, New Orleans, LA

    124. Internet Marketing and Website Development. The American Society of Cataract and Refractive Surgery Annual
        Meeting, April 2001, San Diego, CA

    125. Internet Marketing and Website Development. The American Academy of Ophthalmology Annual Meeting, October
        2000, Dallas, Texas

    126. W. Trattler, J.W. Streilein, and S.W. Cousins, Resistance of the Anterior Chamber to Immunogenic Inflammation
        (Immune Privilege) Can Be Abolished with Gamma Interferon. The Association for Research in Vision and
        Ophthalmology (ARVO), Annual Spring Meeting, May 1990, Sarasota, Florida

    127. W. Trattler, J.W. Streilein, and S.W. Cousins, The Anterior Chamber of the Mouse Eye is Resistant to Delayed
       Type Hypersensitivity Unless Immune Privilege is Abrogated by IF -gamma. The 1990 Eastern Student
       Research Forum, February 1990, Miami, Florida

Moderator/Panelist/Judge Positions

       Moderator:    Symposium on Laser Refractive Surgery; 13TH ANNUAL JOINT MEETING OF OSN, SOI &
                         AICCER; May 10, 2008; Naples, Italy

       Moderator:    KERATOREFRACTIVE LASIK: Presbyopia and Flaps; American Society Of Cataract & Refractive
                     Surgery Annual Meeting; April 6th, 2008; Chicago, IL

       Panelist:     Refractive Surgery Free Paper Session; American Academy of Ophthalmology; New Orleans,
                          LA; Nov 13, ‘07

       Panelist:     My Most Difficult Refractive IOL; Refractive IOL Symposium; Las Vegas, NV; September 30,’07

       Panelist:     Presentations & Panel Discussion: What Treatment Would You Do? Las Vegas, NV;
                          September 30, 2007


                                                             16
                                      William B. Trattler, MD
    Panelist:       Panel and Attendee Discussion: Little Tricks and Pearls that Work; Refractive IOL Symposium;
                         Las Vegas, NV; September 29, 2007

    Moderator:      Debating Today’s Refractive Controversies; Aspen Summer Refractive Congress; July 29, 2007

    Panelist:       Controversies in Ocular Infection, Inflammation, Allergy, and Dry Eye, OSN Las Vegas, June 8, 2007

    Moderator:      Accommodating Intraocular Lenses; The American Society of Cataract & Refractive Surgery Annual
                        Meeting, April 29, 2007; San Diego, CA.

    Poster Judge: The American Society of Cataract & Refractive Surgery Annual Meeting, April 27, 2007,
                       San Diego, CA

    Panelist:       Refractive IOL Symposium; December 3, 2006; Scottsdale, AZ

    Moderator:      Joint Meeting Refractive Free Paper Session, The American Academy of Ophthalmology Annual
                          Meeting, November 13, 2006; Las Vegas, NV

    Panelist:       Corneal Health Roundtable: NSAIDS and Anti-Infectives; Ocular Surgery News 2006 New York
                        Symposium; Manhattan, NY; October 15, 2006

    Poster Judge: The American Society of Cataract & Refractive Surgery Annual Meeting, March 17, 2006,
                       San Francisco, CA

    Moderator:      Dry Eye Symposium, Florida Society of Ophthalmology, December 2005

    Moderator:      Epi-LASIK Outcomes, Indications, Complications; The Fourth International Congress on Epi-LASIK &
                        LASEK, and Advanced Surface Ablation; April 2005, Ft. Lauderdale, FL

    Moderator:      Refractive Surface Ablation Session; The American Society of Cataract & Refractive Surgery Annual
                         Meeting, April 17, 20005, Washington D.C.

    Panelist:       Mechanical and Femtosecond Microkeratomes Session; The American Society of Cataract & Refractive
                        Surgery Annual Meeting, April ‘05, Washington D.C.

    Poster Judge: The American Society of Cataract & Refractive Surgery Annual Meeting, April 16, 2005,
                       Washington D.C.

    Panelist:       Surface Ablation Session; The American Society of Cataract & Refractive Surgery Annual Meeting,
                         May ‘04, San Diego, CA


LECTURES TO LOCAL OPHTHALMOLOGY/MEDICAL GROUPS

    6/3/2008: New Treatments Options for Blepharitis and Meibomian Gland Dysfunction; Miami. FL
    5/21/208: Restasis Roundtable; Houston, TX
    4/2/2008: Optimizing Results with Cataract & Refractive Surgery; Chicago, IL
    2/6/2008: Optimizing results with Cataract & Refractive Surgery; Houston, TX
    11/10/07 Azasite & Topography Lecture; New Orleans, LA
    10/4/07     Azasite & Topography Lecture; Dallas, Tx
    8/30/07     Restasis Smart Start; Tampa, FL
    8/23/07     Restasis Smart Start; Atlanta, GA
    8/09/07     Restasis Smart Start; Dallas, TX
    6/21/07     Optimizing Results with Cataract and Refractive Surgery; Santa Barbara, CA
    3/22/07     Optimizing Results in Cataract and Refractive Surgery; San Francisco, CA
    11/28/06 Update on Research in cataract and refractive surgery, Miami, FL

                                                           17
                                    William B. Trattler, MD
    6/22/06   Optimizing Cataract and Refractive Surgery Results; Jacksonville, FL
    6/10/06   Update on Ocular Allergy & Dry Eye; Las Vegas, NV
    4/11/06   Optimizing Cataract and Refractive Surgery Results; Ft. Lauderdale, FL
    3/29/06   Optimizing Cataract and Refractive Surgery Results; West Palm Beach, FL
    2/10/06   Dry Eye and Ocular Allergy: Coral Springs, FL
    1/10/06   Dry Eye & Refractive Surgery; Miami, FL
    9/15/05   Update on Dry Eye & Ocular Allergy; Tampa, FL
    7/19/05   Understanding Dry Eye & Its Impact on Ocular Allergy; Cedars Sinai Ophthalmology Department
                  Meeting; Los Angeles, CA
    7/19/05   Update on Dry Eye & Ocular Allergy; Glendale Eye Center Quarterly Lecture Series, Los Angeles, CA
    6/29/05   Understanding Dry Eye and Its Impact on Ocular Allergy; Northwest Allergy Group; Seattle, WA
    5/9/05    Controversies in Endophthalmitis Prophylaxis; Miami, FL
    4/1/05    Update on Dry Eye and Ocular Allergy; Allergy Journal Club; Boca Raton, FL
    6/21/04   Refractive Surgery Complications; Update on Ocular Allergy, Ft. Lauderdale, FL
    5/20/04   Refractive Surgery Complications; Update on Ocular Allergy;
                  West Palm Beach Ophthalmology Society; West Palm Beach, FL
    4/22/04   Dry Eye Following Post-LASIK Ectasia; Update on Ocular Allergy; Atlanta, GA
    5/22/03   Update on the Treatment of Dry Eye; Greenville, SC
    5/15/03   Strategies for the Care of Dry Eye Patients; Coconut Grove, FL
    5/01/03   Refractive Surgery Complications; Ocular Allergy Update
                  Augusta Ophthalmology Society, Augusta, GA
    3/29/03   Allergic Eye Disease: Meeting the Challenge of the Season; Dallas, Tx
    3/21/03   Update on Surface ablation; Treatment Options for Ocular Allergy; Jupiter, FL
    4/25/02   Pearls for performing LASEK; Infections following LASIK; Ocular Allergy; Cary, NC
    4/18/02   Pearls for performing LASEK; Infections following LASIK; Ocular Allergy; Chatanooga, TN
    4/17/02   Pearls for performing LASEK; Infections following LASIK; Ocular Allergy; Miami, FL
    4/03/02   Identification and Treatment of Infections following LASIK; Understanding the Mechanisms and
                  Treatment of the Early and Late Phases of Ocular Allergy; Charleston, S.C.
    3/21/02   Understanding the Mechanisms & Treatment of the Early and Late Phases of Ocular Allergy; Jupiter, FL
    3/14/02   Understanding the Mechanisms & Treatment of the Early and Late Phases of Ocular Allergy; Orlando, FL
    1/21/02   Surgical Pearls for the use of Healon 5 and the Pharmacia 911A Silicone lens; Ft. Lauderdale, FL
    8/23/01   Patient Selection for Refractive Surgery: Identifying pts who are poor candidates for LASIK, Atlanta, GA


REVIEWER:
     2005: Ophthalmic Medical Assisting, Fourth Edition; An Independent Study Course; American Academy of
              Ophthalmology; 2006


PEER-REVIEW
     2006 to Present: Journal of Cataract & Refractive Surgery
     2006 to Present Cornea
     2007 to Present American Journal of Ophthalmology


EDITORIAL BOARDS



                                                          18
                                      William B. Trattler, MD
                         Cataract and Refractive Surgery Today
                         EyeNet (Magazine of the American Academy of Ophthalmology)
                         International Ophthalmology Clinics: Associate Editor


PROFESSIO AL ASSOCIATIO S
        Member, American Academy of Ophthalmology (AAO)
                 Chairperson, Refractive Management/Intervention Panel, COMPASS: 2007 to Present
                         Develop online Refractive Management content for an comprehensive online educational tool
                 Member: Ophthalmic Technology Assessment Committee (OTAC) Refractive Surgery Panel; 2006 to
                         Present
                 Member of the Ophthalmic Knowledge Base panel for Refractive Management/Intervention: 2003 to 2007
                 ISRS/RSIG Member
        Member, American Society of Cataract and Refractive Surgery (ASCRS)
        Member, Florida Society of Ophthalmology
        Miami Ophthalmology Society
                 President: January 2006 to December 2006
                 Treasurer: January 2005 to December 2005
                 Secretary: January 2004 to December 2004
        Member with Thesis, The Cornea Society
        American College of Eye Surgeons (ACES)



Surgery Center Affiliations:


Medical Arts Surgery Center:   Miami, FL
Surgical Park:                 Miami, FL




                                                            19

				
DOCUMENT INFO